PFE 2025-04-25 0.61% v 2d 10 14353.1k -5.14% 2018-10-30 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=PFE&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PFE&ty=c&ta=1&p=d
LLY 2025-04-25 2.89% v 6d 14 14174.3k -5.82% 2018-11-06 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=LLY&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=LLY&ty=c&ta=1&p=d
JNJ 2025-04-25 -0.23% v -3d 2 11956.3k -3.70% 2018-10-16 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=JNJ&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=JNJ&ty=c&ta=1&p=d
ABBV 2025-04-25 3.15% v 2d 1 9713.1k -7.99% 2018-11-02 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=ABBV&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ABBV&ty=c&ta=1&p=d
MRK 2025-04-25 3.63% v 1d 20 8599.7k -9.86% 2018-10-25 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=MRK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MRK&ty=c&ta=1&p=d
AMGN 2025-04-25 0.36% v -3d 23 6978.5k -6.46% 2018-10-31 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=AMGN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=AMGN&ty=c&ta=1&p=d
BMY 2025-04-25 -1.62% v -9d 6 6638.8k -6.24% 2018-10-25 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=BMY&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BMY&ty=c&ta=1&p=d
GILD 2025-04-25 -2.81% v -1d 70 5042.2k -4.28% 2018-10-26 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=d
AZN 2025-04-25 0.03% v 3d 13 3699.4k -8.83% 2018-11-08 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=AZN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=AZN&ty=c&ta=1&p=d
BIIB 2025-04-25 -0.56% v -1d 33 3511.8k -7.09% 2018-10-23 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=BIIB&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BIIB&ty=c&ta=1&p=d
NVO 2025-04-25 -0.88% v -2d 4 2243.1k -12.71% 2018-11-07 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=NVO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NVO&ty=c&ta=1&p=d
NVS 2025-04-25 0.87% v 2d 15 2146.1k -4.11% 2018-10-18 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=NVS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NVS&ty=c&ta=1&p=d
GSK 2025-04-25 -0.19% v 6d 17 1341.3k -6.71% 2018-10-24 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=GSK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GSK&ty=c&ta=1&p=d
SNY 2025-04-25 -2.28% v 4d 21 746.1k -7.11% 2018-10-31 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=SNY&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SNY&ty=c&ta=1&p=d
OGN 2025-04-25 0.66% v 2d None 694.4k -15.00% None drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=OGN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OGN&ty=c&ta=1&p=d
GRFS 2025-04-25 0.42% v 9d 8 80.5k -10.19% 2018-11-01 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=GRFS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GRFS&ty=c&ta=1&p=d
HCM 2025-04-25 -7.18% v 3d 83 20.3k -18.95% 2018-03-12 drug manufacturers - general drug manufacturers - general
http://finviz.com/quote.ashx?t=HCM&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=HCM&ty=c&ta=1&p=d
SCLX 2025-04-25 5.42% v -8d None k % None same industry drug manufacturers - general
http://finviz.com/quote.ashx?t=SCLX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SCLX&ty=c&ta=1&p=d
TSVT 2025-04-25 -0.20% v 11d None k % None same industry drug manufacturers - general
http://finviz.com/quote.ashx?t=TSVT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=TSVT&ty=c&ta=1&p=d
MIRA 2025-04-25 4.61% v 0d None k % None same industry drug manufacturers - general
http://finviz.com/quote.ashx?t=MIRA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MIRA&ty=c&ta=1&p=d